Filing Flows › Elite Pharmaceuticals (ELTP) › Operating margin
Elite Pharmaceuticals (ELTP) operating margin by quarter
Elite Pharmaceuticals' operating margin was 23.3% in Q1 FY27 (first quarter fiscal 2027), -1.7 pts from Q4 FY26. Over the last 5 quarters it ranged from 22.6% (Q2 FY26) to 34.9% (Q4 FY25).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | 23.3% | -1.7 pts | — |
| Q4 FY26 | 25.0% | -3.5 pts | -9.9 pts |
| Q3 FY26 | 28.5% | +5.9 pts | — |
| Q2 FY26 | 22.6% | -12.2 pts | — |
| Q4 FY25 | 34.9% | — | — |
Q1 FY27 at a glance
Elite Pharmaceuticals, Q1 FY27: revenue $32.4M (-20% year over year), operating margin 23.3%, net earnings $5.9M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Elite Pharmaceuticals' operating margin?
Elite Pharmaceuticals' operating margin was 23.3% in Q1 FY27 (first quarter fiscal 2027), -1.7 pts from Q4 FY26.
How has Elite Pharmaceuticals' operating margin changed?
Over the last 5 quarters it ranged from 22.6% (Q2 FY26) to 34.9% (Q4 FY25).